| Page 1112 | Kisaco Research
 

Cameron Abid

Business Director, Personal Care, North America
BASF

Cameron Abid

Business Director, Personal Care, North America
BASF

Cameron Abid

Business Director, Personal Care, North America
BASF
 

Romain Gaillard

Founder & CEO
The Detox Market

Romain Gaillard

Founder & CEO
The Detox Market

Romain Gaillard

Founder & CEO
The Detox Market
 

Yashi Shrestha

Head of Science & Research
Novi

Yashi Shrestha is Head of Science & Research at Novi, which is leveraging technology to enable increased ingredient transparency across the value chain and bring more sustainable products to market through its ingredient sourcing and vetting platform.

Yashi Shrestha

Head of Science & Research
Novi

Yashi Shrestha

Head of Science & Research
Novi

Yashi Shrestha is Head of Science & Research at Novi, which is leveraging technology to enable increased ingredient transparency across the value chain and bring more sustainable products to market through its ingredient sourcing and vetting platform.

As the Head of Science & Research, Yashi is responsible for the scientific roadmap and strategy for Novi. Her role includes working closely with retailers, brands, formulators, contract manufacturers, and raw material suppliers to keep Novi’s platform current with the latest available data, new innovations and trends, and emerging policies and standards. 

Yashi believes that the future of product development lies with each stakeholder taking accountability for decisions made at every point in the product development cycle, starting at the design phase. Sustainability can only be achieved by unlocking access to data, which allows tracking, measuring, and making informed decisions, and ultimately development of  more sustainable products  that considers responsible sourcing, end-of-life fate, human health & environment safety, and net positive impact on the planet.

Yashi is a Chemist by training with a focus on Environmental science & Green Chemistry and is currently pursuing her MBA at USC. She was selected as a 30 under 30 honoree by GreenBiz in 2021 and serves as an advisory board member at NakedPoppy.

 

Andrew McGarry

Director of Innovation Success
Ulta Beauty

Andrew McGarry

Director of Innovation Success
Ulta Beauty

Andrew McGarry

Director of Innovation Success
Ulta Beauty
BioViros Lab Opening
 

Johanna Majamaa

Chief Executive Officer
Gekko Vet Oy

Johanna Majamaa

Chief Executive Officer
Gekko Vet Oy

Johanna Majamaa

Chief Executive Officer
Gekko Vet Oy
 

Michael Fishman

Co-Founder and CEO
Maverick Community

Michael Fishman is the Co-Founder and CEO of Maverick Community, shared space gyms that allow top trainers to run their own thriving businesses. Michael currently sits on the Board of Directors of BikeLA, a Los Angeles-based non-profit with a mission to make streets safer for everyone. Prior to starting Maverick, Michael founded Pure Cycles, a bicycle company he started in college at the University of Wisconsin-Madison and earned him a spot on the Forbes 30 Under 30 list in 2014. Michael ran Pure Cycles for 10 years before being acquired in April 2020.

Michael Fishman

Co-Founder and CEO
Maverick Community

Michael Fishman

Co-Founder and CEO
Maverick Community

Michael Fishman is the Co-Founder and CEO of Maverick Community, shared space gyms that allow top trainers to run their own thriving businesses. Michael currently sits on the Board of Directors of BikeLA, a Los Angeles-based non-profit with a mission to make streets safer for everyone. Prior to starting Maverick, Michael founded Pure Cycles, a bicycle company he started in college at the University of Wisconsin-Madison and earned him a spot on the Forbes 30 Under 30 list in 2014. Michael ran Pure Cycles for 10 years before being acquired in April 2020. Michael is born, raised, and is living in Los Angeles with his wife, two kids (3,5), and dog.

 

Aldo Lamberti

Founder
Syntheticus

Aldo Lamberti

Founder
Syntheticus

Aldo Lamberti

Founder
Syntheticus
Interview: Regis Cebe, Principal Scientist II, Novartis
Interview: Roberto De Luca, Head of therapeutic Antibodies, Philochem/Philogen